Decreased serum levels of the inflammaging marker miR-146a are associated with clinical non-response to tocilizumab in COVID-19 patients

References

Page 1

	Year	Citations
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Fei Zhou, Ting Yu, Ronghui Du, The Lancet Clinical CourseEpidemiological TrendRetrospective Cohort StudyPreventive MedicineEpidemiological Outcome	2020	28.8K
Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China Qiurong Ruan, Kun Yang, Wenxia Wang, Intensive Care Medicine Epidemiological TrendVirus EpidemiologyCovid-19 PandemicClinical EpidemiologyCovid-19 Epidemiology	2020	5.1K
Effective treatment of severe COVID-19 patients with tocilizumab Xiaoling Xu, Mingfeng Han, Tiantian Li, Proceedings of the National Academy of Sciences	2020	2.8K
A single-cell atlas of the peripheral immune response in patients with severe COVID-19 Aaron J. Wilk, Arjun Rustagi, Nancy Q. Zhao, Nature Medicine Clinical ImmunologyImmunologyPeripheral Immune ResponseSevere Covid-19Immunologic Disease	2020	1.7K
Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial Ivan Fan-Ngai Hung, Kwok-Cheung Lung, Eugene Yuk-Keung Tso, The Lancet Triple CombinationCovid-19 PandemicAntiviral Drug DevelopmentClinical TrialsAntiviral Therapy	2020	1.6K
A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. Shizuo Akira, Hiroshi Isshiki, Takahisa Sugita, The EMBO Journal InflammationCytokineTranscriptional RegulationNuclear FactorImmunology	1990	1.5K
Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Towia A. Libermann, David Baltimore Molecular and Cellular Biology Immune RegulationImmunologyImmune SystemInflammationIl-6 Promoter	1990	1.4K
Tocilizumab treatment in COVID‐19: A single center experience Pan Luo, Yi Liu, Lin Qiu, Journal of Medical Virology	2020	1.3K
<i>miR-146a</i> is a significant brake on autoimmunity, myeloproliferation, and cancer in mice Mark Boldin, Konstantin D. Taganov, Dinesh S. Rao, The Journal of Experimental Medicine ImmunologyImmune RegulationPathologyInnate ImmunityImmune System	2011	858
CT image visual quantitative evaluation and clinical classification of coronavirus disease (COVID-19) Kunwei Li, Yijie Fang, Wenjuan Li, European Radiology	2020	747

Page 1